跳到正文
EMA Inspections·· 20 天前AI 评分35

EMA发布QRD附录V第36版:各国不良反应报告系统详情(EMA/67830/2013)

QRD Appendix V - Adverse-drug-reaction reporting details

AI 导读

EMA于2026年10月27日发布QRD附录V第36版(EMA/67830/2013),列出各成员国国家不良反应报告系统的具体联系方式,供SmPC第4.8节和包装说明书第4节使用。附录明确印刷包装材料不得引用附录V本身,只能显示相关成员国的实际报告系统详情。

正文 · 原文

Image 1

27 October 2026

EMA/67830/2013,Version 361

Human Medicines Division

APPENDIX V

List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 “Undesirable effects” of SmPC and section 4 “Possible side effects” of package leaflet.

No reference to the Appendix V should be included in the printed packaging materials. Only the actual details of the national reporting system (as listed within this Appendix V) of the concerned Member State(s) shall be displayed on the printed version.

Bracketing convention:

[text]: For guidance only. This text should not be included on the printed packaging materials.

België/Belgique/Belgien

[Dutch]

Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten

www.fagg.be

Afdeling Vigilantie:

Website: www.eenbijwerkingmelden.be

e-mail: adr@fagg-afmps.be

[French]

Agence fédérale des médicaments et des produits de santé

www.afmps.be

Division Vigilance:

Site internet: www.notifieruneffetindesirable.be

e-mail: adr@fagg-afmps.be

[German]

Föderalagentur für Arzneimittel und Gesundheitsprodukte

www.afmps.be

Abteilung Vigilanz:

Website: www.notifieruneffetindesirable.be

e-mail: adr@fagg-afmps.beLietuva

Valstybinė vaistų kontrolės tarnyba prie Lietuvos Respublikos sveikatos apsaugos ministerijos

Tel.: +370 800 73 568

Informacija pranešimo formos pildymui ir pateikimui: https://vvkt.lrv.lt/lt/ България

Изпълнителна агенция по лекарствата

ул. „Дамян Груев“ № 8

1303 София

Te л.: +359 2 8903417

уебсайт:www.bda.bgLuxembourg/Luxemburg

[French]

Centre Régional de Pharmacovigilance de Nancy ou Division de la pharmacie et des médicaments de la Direction de la santé

Site internet : www.guichet.lu/pharmacovigilance

[German]

Centre Régional de Pharmacovigilance de Nancy oder Abteilung Pharmazie und Medikamente (Division de la pharmacie et des médicaments) der Gesundheitsbehörde in Luxemburg

Website : www.guichet.lu/pharmakovigilanz Česko

webového formulářesukl.gov.cz/nezadouciucinky

případně na adresu:

Státní ústav pro kontrolu léčiv

Šrobárova 49/48

100 00 Praha 10

email: farmakovigilance@sukl.gov.czMagyarország

Nemzeti Népegészségügyi és

Gyógyszerészeti Központ

Postafiók 450

H-1372 Budapest

Honlap: www.nngyk.gov.hu

elektronikus úton történő mellékhatás-bejelentés: https://mellekhatas.nngyk.gov.hu

e-mail: adr.box@nngyk.gov.hu Danmark

Lægemiddelstyrelsen

Axel Heides Gade 1

DK-2300 København S

Websted: www.meldenbivirkning.dkMalta

ADR Reporting Website: https://medicinesauthority.gov.mt/adrportal Deutschland

Bundesinstitut für Arzneimittel und Medizinprodukte
Abt. Pharmakovigilanz
Kurt-Georg-Kiesinger-Allee 3
D-53175 Bonn

Website: http://www.bfarm.de

[For vaccines/biological medicinal products]

Bundesinstitut für Impfstoffe und biomedizinische Arzneimittel

Paul-Ehrlich-Institut

Paul-Ehrlich-Str. 51-59

63225 Langen

Tel: +49 6103 77 0

Fax: +49 6103 77 1234

Website:www.pei.deNederland

Nederlands Bijwerkingen Centrum Lareb

Website:www.lareb.nl Eesti

Ravimiamet

Koduleht: www.ravimiamet.ee**Norge**

Direktoratet for medisinske produkter

[For SmPC]

Nettside: www.dmp.no/meldeskjema

[For package leaflet]

Nettside: www.dmp.no/pasientmelding Ελλάδα

Εθνικός Οργανισμός Φαρμάκων

Μεσογείων 284

GR-15562 Χολαργός, Αθήνα

Τηλ: + 30 21 32040337

Ιστότοπος: http://www.eof.gr

http://www.kitrinikarta.grÖsterreich

Bundesamt für Sicherheit im Gesundheitswesen

Traisengasse 5

1200 WIEN

ÖSTERREICH

Fax: + 43 (0) 50 555 36207

Website: http://www.basg.gv.at/ España

Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: www.notificaRAM.esPolska

Departament Monitorowania Niepożądanych Działań Produktów Leczniczych Urzędu Rejestracji Produktów Leczniczych, Wyrobów Medycznych i Produktów Biobójczych

Al. Jerozolimskie 181C

02-222 Warszawa

Tel.: + 48 22 49 21 301

Faks: + 48 22 49 21 309

Strona internetowa:https://smz.ezdrowie.gov.pl France

Agence nationale de sécurité du médicament et des produits de santé (ANSM)

et réseau des Centres Régionaux de Pharmacovigilance

Site internet:https://signalement.social-sante.gouv.fr/Portugal

Sítio da internet: http://www.infarmed.pt/web/infarmed/submissaoram

(preferencialmente)

ou através dos seguintes contactos:
Direção de Gestão do Risco de Medicamentos
Parque da Saúde de Lisboa, Av. Brasil 53

1749-004 Lisboa

Tel: +351 21 798 73 73

Linha do Medicamento: 800222444 (gratuita)

e-mail: farmacovigilancia@infarmed.pt Hrvatska

Agencija za lijekove i medicinske proizvode (HALMED)

Internetska stranica: www.halmed.hrRomânia

Agenţia Naţională a Medicamentului şi a Dispozitivelor Medicale din România

Str. Aviator Sănătescu nr. 48, sector 1

Bucure ş ti 011478- RO

e-mail: adr@anm.ro

Website: www.anm.ro Ireland

HPRA Pharmacovigilance

Website: www.hpra.ieSlovenija

Javna agencija Republike Slovenije za zdravila in medicinske pripomočke
Sektor za farmakovigilanco
Nacionalni center za farmakovigilanco
Slovenčeva ulica 22
SI-1000 Ljubljana
Tel: +386 (0)8 2000 500
Faks: +386 (0)8 2000 510
e-pošta: h-farmakovigilanca@jazmp.si
spletna stran: www.jazmp.si Ísland

til Lyfjastofnunar,www.lyfjastofnun.isSlovenská republika

Štátny ústav pre kontrolu liečiv
Sekcia vigilancie
Kvetná 11
SK-825 08 Bratislava

Tel: + 421 2 507 01 206

e-mail:neziaduce.ucinky@sukl.sk

Tla č ivo na hlásenie podozrenia na ne ž iaduci ú č inok lieku je na webovej stránke www.sukl.sk v č asti Nežiaduce účinky liekov

Formulár na elektronické podávanie hlásení: https://portal.sukl.sk/eskadra/ Italia

Agenzia Italiana del Farmaco

Sito web:

https://www.aifa.gov.it/content/segnalazioni-reazioni-avverseSuomi/Finland

[Finnish]

www-sivusto: www.fimea.fi

Lääkealan turvallisuus- ja kehittämiskeskus Fimea

Lääkkeiden haittavaikutusrekisteri

PL 55

00034 FIMEA

[Swedish]

webbplats: www.fimea.fi

Säkerhets- och utvecklingscentret för läkemedelsområdet Fimea

Biverkningsregistret

PB 55

00034 FIMEA Κύπρος

Φαρμακευτικές Υπηρεσίες

Υπουργείο Υγείας

CY-1475 Λευκωσία

Τηλ: +357 22608607

Φαξ: + 357 22608669

Ιστότοπος: www.moh.gov.cy/phsSverige

Läkemedelsverket

Box 26

751 03 Uppsala

Webbplats:www.lakemedelsverket.se Latvija

Zāļu valsts aģentūra

Jersikas iela 15

Rīga, LV 1003

Tīmekļa vietne: www.zva.gov.lvUnited Kingdom (Northern Ireland)*

Yellow Card Scheme

Website: www.mhra.gov.uk/yellowcardor search for MHRA Yellow Card in the Google Play or Apple App Store

[for COVID-19 products/treatments]

Yellow Card Scheme

Website: https://coronavirus-yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store

  • Not applicable to centrally authorised medicinal products

1 Changes implemented in the different revisions:

V.34: LT details updated (16 December 2025)

V.35: PL and CZ details updated (20 March 2026)

V.36: SK details updated (27 October 2026)

For the UK, as from 1.1.2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI, also referred to as the Windsor Framework.

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands An agency of the European UnionImage 2 Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a questionGo to www.ema.europa.eu/contact**Telephone** +31 (0)88 781 6000

© European Medicines Agency, 2026. Reproduction is authorised provided the source is acknowledged.

来源:EMA Inspections · ema.europa.eu